JDD in the Media

Could You Be Allergic to Additives?

By December 30, 2019February 14th, 2020No Comments
A recent article from US News, “Could You Be Allergic to Additives?” cites a January 2013  JDD study  on whether common additives in food or medications can cause reactions in some people.
The study, “Medication Dyes as a Source of Drug Allergy,” states “Excipients are defined as inert substances added to a drug or food to confer a suitable consistency, appearance, or form. They may be added for bulk, to change dissolution or the kinetics of absorption, to improve stability, to influence palatability, or to create a distinctive appearance. The last function may depend heavily on the use of coloring agents, especially when there are multiple dosages (such as with warfarin), and dose confusion may result in profound complications. While described as inert, excipients have been associated with triggering immunological reactions, although this is almost never considered in common practice when patients have reactions to medications, even when they appear to react to many different and distinct drugs.”
Read Article Now

You May Also Like

Atopic DermatitisDermatology RoundupGlobal HealthJDD HighlightsJDD in the MediaSkin CancerThe Latest
November 20, 2024

Dermatology Roundup: Medicare Fee Schedule to Cut Physician Pay; Telemedicine Tool Found Accurate in Melanoma Diagnosis

By Allison Sit The American Academy of Dermatology (AAD) is joining with other specialties in speaking out about cuts to the Medicare Physician Fee Schedule for 2025. The physician services…
AcneDerm CommunityFeatured ArticlesJDD HighlightsJDD in the MediaThe Latest
November 14, 2024

JDD in the News: Hyperhidrosis & Sensitive Skin Connection; Dermatitis from Poppers

By Allison Sit Dermatology Advisor and Physician’s Weekly each shared a HealthDay article about a JDD study on a possible relationship between hyperhidrosis and sensitive skin. The study, “Primary Hyperhidrosis…
Atopic DermatitisDermatology RoundupJDD HighlightsJDD in the MediaThe Latest
October 17, 2024

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

By Allison Sit Semaglutide – a glucagon-like peptide (GLP)-1RA – improved outcomes for obese patients with hidradenitis suppurativa (HS), according to a study presented at EADV Congress 2024. The study…

Leave a Reply